TRACEY COLEMAN: Open Payments
NPI 1780936864 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 40 payments from 13 companies in 2025. Trend: 2023 $863 · 2024 $846 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 6 | $196 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| ABIOMED | 5 | $134 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| BridgeBio Pharma, Inc. | 3 | $74 |
| PFIZER INC. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $42 |
| Recor Medical Inc | 1 | $35 |
Products named: Barostim Neo System, FARXIGA, VERQUVO, Attruby, VYNDAQEL, Kerendia, JARDIANCE, FUROSCIX.
Industry payments across SC — which companies pay providers there.
